Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
CTNNB1
REST API REST API
Homo sapiens
CTNNB1 is differentially expressed in 279 experiments: 132 organism parts: bone marrow, lung, ... (130 more);, 174 disease states: normal, acute myeloid leukemia, ... (172 more);, 82 cell types 361 cell lines 36 compound treatments and 70 other conditions.
Synonyms CTNNB, beta-catenin
Orthologs CTNB1_BOVIN (Bos taurus)   Q9NL44_CIOIN (Ciona intestinalis)   CTNNB1 (Gallus gallus)   Ctnnb1 (Rattus norvegicus)   Ctnnb1 (Mus musculus)   VAC8 (Saccharomyces cerevisiae)   arm (Drosophila melanogaster)   ctnnb1 (Xenopus laevis)   B6V8E6_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, plasma membrane, spindle pole, DNA binding, adherens junction, cell morphogenesis involved in differentiation, negative regulation of transcription, DNA-dependent, protein binding, apoptosis, cellular process, regulation of transcription, DNA-dependent, glial cell fate determination, cell-cell adherens junction, cytoskeleton, cytoplasm, cell-cell adhesion, embryonic heart tube development, double-stranded DNA binding, cell proliferation, regulation of cell proliferation, cadherin binding, cell cortex, negative regulation of cell proliferation, trachea morphogenesis, cell fate determination, cell-cell junction, determination of dorsal/ventral asymmetry, protein complex, transcription, DNA-dependent, positive regulation of cell proliferation, positive regulation of gene expression, membrane, negative regulation of apoptosis, endoderm formation, kinase binding, male genitalia development, structural molecule activity, embryonic foregut morphogenesis, cytoskeletal anchoring at plasma membrane, membrane fraction, cell fate specification, cell junction, proximal/distal pattern formation, positive regulation of apoptosis, oocyte development, signal transducer activity, transcription factor binding, cell differentiation, midgut development, synapse organization, synaptic vesicle transport, response to cadmium ion, basolateral plasma membrane, anterior/posterior axis specification, cell adhesion, hemopoiesis, neuron projection, positive regulation of transcription from RNA polymerase II promoter, Wnt receptor signaling pathway, zonula adherens, centrosome, synaptic transmission, cell-matrix adhesion, transcription coactivator activity, protein kinase binding, nucleus, muscle cell differentiation, heart development, lamellipodium, canonical Wnt receptor signaling pathway, regulation of cell differentiation, response to hormone stimulus, transcription factor complex, embryonic axis specification, response to drug, perinuclear region of cytoplasm, synapse, apical part of cell, chromatin binding, SMAD binding, protein C-terminus binding, negative regulation of transcription from RNA polymerase II promoter, negative regulation of cell differentiation, regulation of transcription from RNA polymerase II promoter, apical junction complex, ectoderm development, enzyme binding, epithelial to mesenchymal transition, lateral plasma membrane, positive regulation of transcription, DNA-dependent, morphogenesis of embryonic epithelium, dorsal/ventral axis specification, regulation of apoptosis, dorsal/ventral pattern formation, Z disc, positive regulation of mesenchymal cell proliferation, renal inner medulla development, cell-substrate adherens junction, endothelial tube morphogenesis, positive regulation of I-kappaB kinase/NF-kappaB cascade, regulation of smooth muscle cell proliferation, response to cytokine stimulus, androgen receptor binding, androgen receptor signaling pathway, genitalia morphogenesis, regulation of epithelial cell differentiation, endodermal cell fate commitment, internal side of plasma membrane, regulation of angiogenesis, RPTP-like protein binding, cellular response to growth factor stimulus, negative regulation of oligodendrocyte differentiation, regulation of calcium ion import, mesenchymal to epithelial transition involved in metanephros morphogenesis, regulation of T cell proliferation, epithelial tube branching involved in lung morphogenesis, lung induction, microvillus membrane, regulation of fibroblast proliferation, in utero embryonic development, kidney development, lens morphogenesis in camera-type eye, branching involved in ureteric bud morphogenesis, hindbrain development, embryonic hindlimb morphogenesis, limb development, negative regulation of osteoclast differentiation, adherens junction assembly, central nervous system vasculogenesis, forebrain development, gastrulation with mouth forming second, regulation of centromeric sister chromatid cohesion, trachea formation, lung-associated mesenchyme development, positive regulation of anti-apoptosis, cell projection membrane, hair follicle morphogenesis, response to estrogen stimulus, protein-DNA complex, positive regulation of branching involved in lung morphogenesis, alpha-catenin binding, pancreas development, vasculogenesis, myoblast differentiation, epithelial cell differentiation involved in prostate gland development, cellular response to indole-3-methanol, nephron tubule formation, metanephros morphogenesis, embryonic digit morphogenesis, nuclear hormone receptor binding, estrogen receptor binding, catenin complex, cell maturation, cellular protein localization, regulation of osteoblast differentiation, skin development, fascia adherens, renal outer medulla development, hair follicle placode formation, skeletal system development, negative regulation of chondrocyte differentiation, desmosome, regulation of centriole-centriole cohesion, regulation of osteoclast differentiation, regulation of myelination, positive regulation of endothelial cell differentiation, response to estradiol stimulus, organ development, lung development, tongue morphogenesis, positive regulation of epithelial cell proliferation involved in prostate gland development, positive regulation of osteoblast differentiation, patterning of blood vessels, positive regulation of epithelial cell differentiation, lung cell differentiation, mesenchymal cell proliferation involved in lung development, liver development, bone resorption, beta-catenin-TCF7L2 complex, positive regulation of heparan sulfate proteoglycan biosynthetic process, ionotropic glutamate receptor binding, protein phosphatase binding, hair cycle process, thymus development, odontogenesis of dentine-containing tooth, smooth muscle cell differentiation, protein localization at cell surface, positive regulation of MAPKKK cascade, embryonic limb morphogenesis, renal system development, T cell differentiation, dendritic shaft, positive regulation of muscle cell differentiation, Axin-APC-beta-catenin-GSK3B complex, positive regulation of fibroblast growth factor receptor signaling pathway, R-SMAD binding, embryonic arm morphogenesis, renal vesicle formation, I-SMAD binding, Schwann cell proliferation, osteoclast differentiation, sequence-specific DNA binding transcription factor activity, T cell differentiation in thymus, cellular component disassembly involved in apoptosis, negative regulation of heart induction by canonical Wnt receptor signaling pathway, oviduct development, canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition, embryonic leg joint morphogenesis, regulation of nephron tubule epithelial cell differentiation, fungiform papilla formation, cell periphery, positive regulation of determination of dorsal identity, Scrib-APC-beta-catenin complex, response to organic cyclic compound, regulation of protein localization at cell surface, canonical Wnt receptor signaling pathway involved in negative regulation of apoptosis, APC-Axin-1-beta-catenin complex, regulation of secondary heart field cardioblast proliferation, cellular response to organic cyclic compound, transcription regulatory region DNA binding, repressing transcription factor binding, ion channel binding
InterPro Term Armadillo, Beta-catenin
Gene-Disease Assocation OVARIAN CANCER, SALIVARY GLAND ADENOMA, PLEOMORPHIC, HEPATOCELLULAR CARCINOMA, PILOMATRIXOMA, COLORECTAL CANCER; CRC, MEDULLOBLASTOMA; MDB
UniProt Accession P35222, C9IZ65, B2ZRG2, B2ZRE2, B4DGU4, E7EMJ5, E7EV28, E9PDF9
Search EB-eye ENSG00000168036
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-AFMX-5, E-MEXP-1251, E-MTAB-24, E-MTAB-25, ... (23 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-19639, E-GEOD-18005, E-GEOD-2450, ... (36 experiments)

Factor Value U/D Experiments
MCF-7
4
E-GEOD-19639, E-GEOD-3529, E-GEOD-20081, E-GEOD-5823
DU145
2
E-GEOD-17482, E-GEOD-20089
HepG2
2
E-GEOD-7307, E-MTAB-37
LNCaP
2
E-GEOD-14464, E-GEOD-14990
SW480
2
E-MEXP-1014, E-MTAB-37
primary culture
2
E-GEOD-2450, E-GEOD-1657
355 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-3920, E-GEOD-13909, E-GEOD-20677, E-GEOD-13987, ... (45 experiments)

Factor Value U/D Experiments
1
2
E-TABM-145, E-TABM-130
plasma cell
2
E-MEXP-2360, E-GEOD-6691
lung carcinoma
1
E-GEOD-17347
stimulated polymorphonuclear leukocyte
1
E-GEOD-935
CD34+ cell
1
E-MEXP-583
n/a
1
E-MTAB-24
76 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-MEXP-1121, E-MTAB-62, ... (51 experiments)

Factor Value U/D Experiments
Huntington's disease
2
E-AFMX-6, E-GEOD-3790
gastric carcinoma
2
E-MTAB-37, E-GEOD-2685
lung adenocarcinoma
2
E-MTAB-62, E-MTAB-37
melanoma
2
E-MTAB-62, E-MTAB-37
prostate carcinoma
2
E-MTAB-62, E-GEOD-96
uterine fibroid
2
E-MTAB-62, E-GEOD-7307
168 more value(s).


Compound treatment

studied in E-GEOD-6907, E-GEOD-15205, E-TABM-782, E-GEOD-3720, E-TABM-868, ... (24 experiments)

Factor Value U/D Experiments
none
9
E-GEOD-412, E-MEXP-1601, E-MEXP-1958, E-TABM-868, E-TABM-782, ... (9 experiments)
lipopolysaccharide
2
E-MEXP-1958, E-TABM-868
placebo
2
E-MEXP-1335, E-MEXP-1327
saline
1
E-GEOD-3026
TNF
1
E-GEOD-15205
bacterial endotoxin
1
E-GEOD-3284
30 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-TABM-125, E-GEOD-21374, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-MEXP-1251, E-GEOD-21374, E-GEOD-21589, ... (9 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-MEXP-2359, E-GEOD-4667, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-TABM-147, E-GEOD-21138, E-GEOD-3013 ... (5 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, ... (8 experiments)

Genotype
studied in E-TABM-1029, E-GEOD-2466, E-GEOD-17476, E-MEXP-421, E-TABM-321, ... (11 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-5681, E-GEOD-7011, E-MEXP-2657, E-GEOD-20504, ... (10 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-16194, E-GEOD-21653, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-MEXP-2069, E-GEOD-1926, E-MEXP-1648, ... (37 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254, E-MEXP-561, E-GEOD-17400

Labeling
studied in E-LGCL-5

Light
studied in E-GEOD-1725

Localisation of metastases
studied in E-GEOD-22541

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-AFMX-1, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-19703, E-GEOD-1657, E-GEOD-1460, E-GEOD-17636

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246 ... (5 experiments)

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-10797, E-GEOD-18791, E-GEOD-10896

RNAi
studied in E-MEXP-101, E-GEOD-3697, E-MEXP-1857, E-MEXP-2759

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-21374

Sex
studied in E-GEOD-2466, E-GEOD-22541, E-GEOD-7307

Stimulation
studied in E-GEOD-4883, E-GEOD-20114, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-GEOD-1926, E-TABM-276, E-GEOD-2748

Treatment
studied in E-GEOD-22152, E-MEXP-973, E-GEOD-19246, E-GEOD-13818, E-GEOD-19815, ... (6 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Ttf
studied in E-GEOD-21521

Tumor grading
studied in E-GEOD-89, E-GEOD-4290, E-GEOD-4271, E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.448 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM